Background & Aims Recommendation of surveillance colonoscopy should be based on risk
of colorectal cancer and death after adenoma removal. We aimed to develop a risk …

In the United States, colorectal cancer (CRC) is the third most common cancer diagnosed
among men and women and the second leading cause of death from cancer. CRC largely …

Polyp size is a critical biomarker for clinical management. Larger polyps have a greater
likelihood of being or of becoming an adenocarcinoma. To balance the referral rate for …

This document is the first update of the American College of Gastroenterology (ACG)
colorectal cancer (CRC) screening recommendations since 2000. The CRC screening tests …

Background There is growing evidence that faecal-occult-blood (FOB) screening may
reduce colorectal cancer (CRC) mortality, but this reduction in CRC mortality has not been …

Oxidative phosphorylation (OXPHOS) defects caused by somatic mitochondrial DNA
mutations increase with age in human colorectal epithelium and are prevalent in colorectal …

Background: Previous studies have documented significant variations in colorectal cancer
incidence rates and trends regionally and across countries. However, no study has …

Background Case-control studies and a voluntary-based follow-up study have suggested
that repeated screening with faecal-occult-blood (FOB) tests can lead to a reduction in …

Adenomatous polyps are the most common neoplastic findings discovered in people who
undergo colorectal screening or who have a diagnostic work-up for symptoms. It was …

We have updated guidelines for screening for colorectal cancer. The original guidelines
were prepared by a panel convened by the US Agency for Health Care Policy and Research …